'Drug target' presentation slideshows

THE COMBINED USE OF COMPARATIVE SYSTEMS BIOLOGY AND STRUCTURE-BASED APPROACHES

THE COMBINED USE OF COMPARATIVE SYSTEMS BIOLOGY AND STRUCTURE-BASED APPROACHES FOR THE DEVELOPMENT OF SELECTIVE ENZYMES INHIBITORS AS LEAD DRUGS AGAINST TRYPANOSOMATID PARASITES. The medical problem.

1.03k views • 88 slides

Drug Discovery and Development

965 views • 62 slides

MALARIA RESEARCH PROGRAM Department of Biochemistry University of Pretoria

859 views • 62 slides

V27 Cellular Drug Network

V27 Cellular Drug Network. How many drug targets are there? in 2002: ~8,000 targets of pharmacological interest, of which nearly 5,000 could be potentially hit by traditional drug substances, nearly 2,400 by antibodies and ~800 by protein pharmaceuticals.

611 views • 47 slides

Instructor: Dr. Marinella Sandros

631 views • 46 slides

Forces Involved in Drug-biomolecule Target Interactions: Intermolecular Forces Binding Equilibria

Forces Involved in Drug-biomolecule Target Interactions: Intermolecular Forces Binding Equilibria. Noncovalent binding equilibria. Binding: noncovalent, reversible association (and dissociation) between molecules

570 views • 41 slides

How many drug targets are there?

How many drug targets are there? In 2002, after the sequencing of the human genome, others arrived at ~8,000 targets of pharmacological interest, of which nearly 5,000 could be potentially hit by traditional drug substances, nearly 2,400 by antibodies and ~800 by protein

751 views • 40 slides

Chapter 13. Drug Design and Discovery

Chapter 13. Drug Design and Discovery. Drug Discovery. Average time to bring a drug to market is 12-15 years. Average cost is $600-800 million. For every 20,000 compounds evaluated in animals, 10 make it to human clinical trials, of which 1 goes to market. Clinical Trials.

1.18k views • 38 slides

Conformational Ensembles Docking

BL5203: Molecular Recognition & Interaction Lecture 5: Drug Design Methods Ligand -Protein Docking (part II) Prof. Chen Yu Zong Tel: 6874-6877 Email: csccyz@nus.edu.sg http://xin.cz3.nus.edu.sg Room 07-24, level 7, SOC1, National University of Singapore. Conformational Ensembles Docking.

657 views • 35 slides

438 views • 32 slides

The Goal:

Integration of chemical-genetic & genetic interaction data links bioactive compounds to cellular target pathways Parsons et al. 2004 Nature Biotechnology Jed Shimizu Medical Genetics 505 March 31, 2005. The Goal:. Identifying targets of possible drugs. Gene A. Bioactive compound.

461 views • 31 slides

Intellectual Property Case Study

Intellectual Property Case Study. The Case. Prof. Andrews is a Professor within the School of Chemistry at the University of the East Midlands (UoEM).

470 views • 29 slides

Data Structures and Algorithms

695 views • 27 slides

361 views • 19 slides

330 views • 16 slides

Bio5663 Neurobiology of Disease

Bio5663 Neurobiology of Disease. Chris Weihl Brad Schlaggar TA Erica Pehrsson. Course Objectives. Logistics Expectations. Schedule/Website. 2012 Schedule. Translational Neuroscience. Definitions. Bayer HealthCare Internal study with 23 labs and 67 projects 70% Oncology

312 views • 8 slides

Bioinformatics

Bioinformatics. Jean-Christophe (JC) Nebel Bioinformatics & Genomic Signal Processing Group j.nebel@kingston.ac.uk Kingston University London. What is bioinformatics?. Bioinformatics : word was coined in 1978 Bio- : life Informatics : information systems & computer science

323 views • 6 slides

H3N2 Infection Therapeutic Development, H1 2015

243 views • 6 slides

Graft Versus Host Disease Therapoeutic Development 2015

315 views • 6 slides

Mild Psoriasis Pipeline Review and Drug Target Report 2015

Mild Psoriasis Pipeline Review, H1 2015 is Now Available at RnRMarketResearch.Com This report provides comprehensive information on the therapeutic development for Mild Psoriasis, complete with comparative analysis at various stages.

252 views • 6 slides